Mr. Anderson, I'll make a couple of comments on that.
On the side of narrowing the technology gap, if we have products that aren't in Canada right now—and part of this package is to use Project 914 to narrow this technology gap—we basically are going to have to have companies interested in registering products that they haven't previously had an interest in or haven't pursued an interest in registering.
When that product becomes registered in Canada, those companies are going to be interested in what kind of intellectual property protection they're going to have for this new product. One scenario could be that there is a generic of one of those products already in the U.S. There would be concern on the companies' side as to why they would want to introduce it into Canada if that product could then be brought in on the generic side almost immediately if equivalency could be proved.
So there is reason to believe we're not going to get the kind of uptake on narrowing the technology gap as long as that old OUI program is in place. As Karen mentioned, under the GROU program, if there were a generic version of one of those products in the U.S. and you deemed equivalency, you would basically have already said that the product could come in. I think that's why companies are not interested in telling us what is on the GROU list until they know the status of the OUI program.